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a  b  s  t  r  a  c  t
Nocardia spp. are a group of aerobic actinomycetes widely distributed in soil, and associated
with severe opportunistic infections, essentially pulmonary infections.
We  report the ﬁrst case of disseminated infection associated with urinary tract infection
caused by Nocardia veterana. The diagnosis was difﬁcult; despite the presence of pulmonary
nodules, the lung biopsies remained negative while only one aerobic blood culture and
the urine culture were positive for N. veterana, identiﬁed after a 16S rDNA gene sequence
analysis.
Few cases of clinical importance due to N. veterana have been published since its charac-
terization. The bacteriological diagnosis of nocardiosis can be difﬁcult to establish because
of  the delayed growth and the speciﬁc techniques that are required. This case illustrates
the  necessity of performing speciﬁc investigations in immunocompromised patients whopresent with infectious disease because the severity of this infection requires early diagnosis
and quick initiation of appropriate antibiotic therapy.
©  2015 Elsevier Editora Ltda. All rights reserved.
toma, diagnosed 11 months before, and multicystic kidneyCase  presentationA 51-year-old man  was admitted to the hospital to investi-
gate his chest pain and weight loss (8 kg in two months). His
Abbreviations: CAPD, continuous ambulatory peritoneal dialysis;
deoxyglucose labeled with ﬂuorine 18; PAS, periodic acid Schiff; PCR, p
desorption/ionization time-of-ﬂight mass spectrometry.
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1413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.past medical history included a grade 4 left temporal glioblas- BAL, bronchoalveolar lavage; CT, computed tomography; FDG,
olymerase chain reaction; MALDI-TOF MS, matrix-assisted laser
 Anne, Boulevard Sainte Anne, BP 20545, 83041 Cedex 09 Toulon,
disease. The patient underwent surgery and radiation ther-
apy, followed by ﬁrst line chemotherapy with temozolomide
and second line chemotherapy with lomustine, vincristine,
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Fig. 1 – Chest CT scan showing right-sided multiple
pulmonary nodules with cavitation (A) and parenchymal
consolidation in the middle lobe (B).
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Fig. 2 – PET scan showing an intense and diffuse
accumulation of the FDG in the prostate (A: PET imaging; B:
scanned imaging of the prostate).nd procarbazin, due to disease progression. He was given
2 mg  of methylprednisolone per day starting at the beginning
f the chemotherapy. Multicystic kidney disease caused renal
erminal insufﬁciency, which required continuous ambula-
ory peritoneal dialysis (CAPD) for more  than four months.
he patient presented with a progressive shortness of breath,
ight-sided chest pain, and dysuria. He had no fever, and a
hysical exam showed right basal crackles. The laboratory
est results were as follows: hemoglobin 9.7 g/dL; neutrophils
2 × 109/L; lymphocytes 4.2 × 109/L with a CD4 lympho-
yte count of 1.64 × 109/L; serum creatinine 630 mol/L, and
-reactive protein 113.5 mg/L (reference value <10 mg/L). Addi-
ionally, two sets of blood cultures and urine culture were
erformed. Urine analysis revealed 1.3 × 106 leukocytes/mL
normal range <103/mL) and Gram-positive short bacilli at
icroscopic examination. Chest computed tomography (CT)
howed multiple sub-pleural nodules in the right lower lobe
hat were adjacent to pleural thickening without pleural effu-
ion, and consolidation in the middle lobe (Fig. 1). One of
he nodules was excavated. The PET imaging performed to
emonstrate deep infection showed an intense and diffuse
ccumulation of the deoxyglucose labeled with ﬂuorine 18
FDG) in the prostate (Fig. 2) revealing prostatitis.
A bronchoalveolar lavage (BAL) and a CT-guided needle
ung biopsy of the posterior nodule were performed. In the
aboratory, tissue analysis found acute suppurative inﬂam-
ation, with negative PAS, Grocott and Giemsa staining.Gram and acid-fast staining were processed and were neg-
ative on both samples. Standard culture performed on BAL
was non-contributive, with polymicrobial non-pathogenic
nasopharyngeal ﬂora; mycobacterial and mycological cultures
remained negative. Standard culture was not undertaken on
the pulmonary biopsy because of its insufﬁcient amount. Both
samples were tested for tuberculosis using polymerase chain
reaction (PCR) on the MTB/RIF test platform (GenExpert®;
Cepheid, Sunnyvale, CA, USA) and were negative. PCR ampli-
ﬁcation and sequencing of 16S rDNA and 18S rDNA for the
detection of bacteria and fungi, respectively, were performed
on the pulmonary biopsy after dewaxing, and were negative.
Four days after the patient’s admission, growth was identiﬁed
in one aerobic blood culture using the BacT Alert 3D® culture
system (BioMérieux, Marcy  l’Etoile, France). The bacterium
was a non-motile, Gram-positive organism with branching ﬁl-
aments. Small, chalky white, rough colonies grew within 48 h
when inoculated on boiled blood agar plates that were incu-
bated at 37 ◦C in 5% CO2. They were partially acid-fast and were
considered to likely represent Nocardia spp. A Gram-positive
bacterium was observed simultaneously in the urine culture,
with more  than 100,000 colonies/mL. The two strains, from
blood and urine cultures, were identiﬁed to the genus level as
Nocardia spp. using the MALDI-TOF MS (matrix-assisted laser
desorption–ionization time-of-ﬂight mass spectrometry) sys-
tem (Bruker Daltonik, Bremen, Germany) after an extraction
procedure. The identiﬁcation to the species level as Nocardia
veterana was obtained using a 16S rDNA gene sequence analy-
sis (99.9% sequence matching with the type strain N. veterana
DSM 44445T).
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Prior to the isolation of Nocardia, the patient was
empirically treated with intravenous trimethoprim-
sulfamethoxazole (400 mg/80 mg,  twice daily) and ceftriaxone
(750 mg  twice daily). Doses were adapted to renal function,
with hemodialysis performed three times per week. Antimi-
crobial susceptibility was assessed by the French Observatory
of Nocardiosis (Lyon, France) by broth microdilution accord-
ing to the Clinical and Laboratory Standards Institute (CLSI0
methods and breakpoints).1 The proﬁle revealed resistance to
amoxicillin + clavulanate (MIC of 32/16 g/mL), ciproﬂoxacin
(MIC >4 g/mL) and doxycycline (MIC = 8 g/mL); intermediate
susceptibility to gentamicin (MIC of 8 g/mL) and minocyclin
(MIC = 2 g/mL); and susceptibility to cefotaxime (≤4 g/mL),
ceftriaxone (MIC = 8 g/mL), imipenem (MIC ≤ 2 g/mL),
trimethoprim-sulfamethoxazole (MIC ≤ 1/19 g/mL) and
linezolid (MIC ≤ 4 g/mL). After initiation of treatment, the
respiratory symptoms slowly improved, and dysuria was
completely resolved. The biological inﬂammatory syndrome
decreased gradually, and a chest CT scan performed after
one month of antibiotic therapy showed a moderate decrease
in nodules size. Accordingly, the urinary and blood culture
controls showed no remaining Nocardia. Unfortunately, due
to glioblastoma progression, the patient’s neurological status
declined, and he died two months after the initial admission.
Nocardiosis infections are caused by the saprophytic
aerobic, Gram-positive, branching and ﬁlamentous bacilli
belonging to the genus Nocardia. The identiﬁcation of Nocar-
dia isolates at the species level is critical for deﬁning the
spectrum of diseases that are caused by each species and to
predict antimicrobial susceptibility.2 To date, approximately
90 species have been described (NCBI taxonomy for Nocardia),
and a third of them have been implicated in human disease.3
If isolates grow well on blood agar plates, the routine identi-
ﬁcation of Nocardia strains using conventional phenotypical
methods is a fastidious and time-consuming process that
is now restricted to reference centers.2 In recent years, 16S
rDNA gene sequence analysis has become accessible to clin-
ical laboratories for deﬁnitive species identiﬁcation.4 In our
case, the strain of N. veterana was conﬁrmed at the species
level by almost complete 16S rDNA gene sequencing (1315
nt) by using SQ1 (5′-AGAGTTGATCMTGGCTCAG-3′) and SQ6
(5′-CGGTGTGTACAAGGCCC-3′) primers, according to previous
published data.5 The sequences obtained presented a 99.9%
sequence similarity (one difference out of 1315 nt, exclud-
ing the primers) to the type strain N. veterana DSM 44445T.
The MALDI-TOF MS  identiﬁcation systems are based on the
comparison of the tested isolate mass spectrum with ref-
erence databases. Previous studies reported that the Bruker
MALDI-TOF MS  system accurately identiﬁed species from the
genus Nocardia spp.6 but a preliminary extraction step was
mandatory to obtain satisfactory results. In our case, the iden-
tiﬁcation was obtained to the genus level after an extraction
procedure in two steps (boiling followed by ethanol–formic
acid extraction). At ﬁrst, the identiﬁcation by the direct colony
method failed to identify the bacterium, although it has been
recently published with other MALDI-TOF MS  systems.7
8N. veterana is a species that was characterized in 2001. The
difﬁculties in the identiﬁcation of this species, until recently,
may imply that it is more  common as a human pathogen
than previously reported.9 Indeed, little is known about N. 1 5;1  9(2):216–219
veterana because few cases of clinical importance have been
published. One isolate was from a brain abscess10; three were
reported in patients with pulmonary infections2,11–14; one
isolate was recovered in a bowel abscess and was associ-
ated with colon carcinoma15; two cases of mycetomas from
Japan were published16,17; one isolate has been recovered
from ascitic ﬂuid,8 one was responsible for an endogenous
endophtalmitis,18 and recently, a case of N. veterana causing
nodular lymphangitis was reported.19 Bloodstream infection
due to N. veterana is a rare condition. In our case, this pathogen
was isolated from blood and urine cultures, and this is the ﬁrst
reported case of urinary tract infection due to N. veterana. This
implies that the infectious spectrum of N. veterana could be
relatively broad.
Like other species of Nocardia spp., N. veterana causes infec-
tions mainly in immunocompromised hosts. As predisposing
factors, the patient was administered long-term corticosteroid
and chemotherapy (including temozolomide) for neoplas-
tic disease. However, in a recent study of nocardiosis and
AIDS, it was shown that despite deep immunodepression,
nocardiosis was an uncommon complication. Trimethoprim-
sulfamethoxazole, which is used in primary prophylaxis for
toxoplasmosis, could be effective against nocardiosis as well.
It is unclear how our patient became infected by N. veterana.
Pulmonary infection is the most common site of nocardiosis,
and it is usually acquired by inhalation of sporulated frag-
mented nocardial mycelia found in the environment.11,20 Most
of the time, diagnosis is based on the isolation of Nocardia from
respiratory samples. In our case, we identiﬁed a disseminated
N. veterana infection with the presence of this bacterium in
peripheral blood culture and urine. The hypothesis of airborne
contamination, with an infection that was initially limited to
the lung and a secondary hematological dissemination, some-
times to the central nervous system and soft tissue,8 may be
considered. However, we have not proved the presence of N.
veterana in the chest, although there were several indications
of its presence, including the patient’s pulmonary presenta-
tion, chest CT scan features with nodules and parenchymal
consolidation12 (Fig. 1) and the negativity of all bacteriolog-
ical chest sampling for other pathogens. The contamination
of the BAL by non-pathogenic nasopharyngeal ﬂora of the
upper respiratory tract could have interfered with culturing
of Nocardia spp. We have no explanation for the negativity of
PCR ampliﬁcation of 16S rDNA performed on the pulmonary
biopsy after dewaxing; the low sensitivity of PCR ampliﬁca-
tion could explain the result. Furthermore, the role of CAPD
must be considered, as several cases of peritoneal nocardio-
sis have been reported.21 Our patient had daily home- and
self-made CAPD, which could have been a predisposing fac-
tor for this infection because of non-optimal skills. We did
not perform bacteriological testing of ascitic ﬂuid because our
patient had no abdominal pain, which makes the hypothesis
of CAPD-induced contamination less likely.
The antimicrobial agents to be used against N. veter-
ana remain controversial due to discrepancies regarding
methodological variations, differences in interpretations con-
cerning breakpoints and, therefore, susceptibilities. Based on
limited in vitro studies of antimicrobial agents against this
microorganism, the empiric drug of choice for this pathogen
would be trimethoprim-sulfamethoxazole9,22 at a dose of
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0–15 mg/kg daily. In our case, N. veterana remained sensitive
o trimethroprim-sulfamethoxazole and ceftriaxone, which
as the initial empirical treatment. The treatment of nocar-
iosis must be extended by considering many  factors, such
s the severity of infection or the immunizing status. In the
reviously published cases, the duration of treatment ranged
rom a few weeks to a number of years based on expert opin-
on on the treatment of other Nocardia infections.10 Because
he patient died two months after the initial admission, we
ould not evaluate his response to the antibiotic treatment.
onclusion
n conclusion, this is the ﬁrst reported case of urinary tract
nfection due to N. veterana. Nocardiosis due to N. veterana is a
are disease, but its incidence will most likely increase in the
oming years because of the growing population of immuno-
ompromised hosts. This case illustrates the difﬁculty of
stablishing a bacteriological diagnosis of nocardiosis and the
ecessity of performing speciﬁc investigations in immuno-
ompromised patients who present with infectious disease
ecause the severity of this infection requires early diagnosis
nd quick initiation of appropriate antibiotic therapy.
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